Previous lung diseases and lung cancer risk: a systematic review and meta-analysis
- PMID: 21483846
- PMCID: PMC3069026
- DOI: 10.1371/journal.pone.0017479
Previous lung diseases and lung cancer risk: a systematic review and meta-analysis
Abstract
Background: In order to review the epidemiologic evidence concerning previous lung diseases as risk factors for lung cancer, a meta-analysis and systematic review was conducted.
Methods: Relevant studies were identified through MEDLINE searches. Using random effects models, summary effects of specific previous conditions were evaluated separately and combined. Stratified analyses were conducted based on smoking status, gender, control sources and continent.
Results: A previous history of COPD, chronic bronchitis or emphysema conferred relative risks (RR) of 2.22 (95% confidence interval (CI): 1.66, 2.97) (from 16 studies), 1.52 (95% CI: 1.25, 1.84) (from 23 studies) and 2.04 (95% CI: 1.72, 2.41) (from 20 studies), respectively, and for all these diseases combined 1.80 (95% CI: 1.60, 2.11) (from 39 studies). The RR of lung cancer for subjects with a previous history of pneumonia was 1.43 (95% CI: 1.22-1.68) (from 22 studies) and for subjects with a previous history of tuberculosis was 1.76 (95% CI=1.49, 2.08), (from 30 studies). Effects were attenuated when restricting analysis to never smokers only for COPD/emphysema/chronic bronchitis (RR=1.22, 0.97-1.53), however remained significant for pneumonia 1.36 (95% CI: 1.10, 1.69) (from 8 studies) and tuberculosis 1.90 (95% CI: 1.45, 2.50) (from 11 studies).
Conclusions: Previous lung diseases are associated with an increased risk of lung cancer with the evidence among never smokers supporting a direct relationship between previous lung diseases and lung cancer.
Conflict of interest statement
Figures



Similar articles
-
Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema.BMC Pulm Med. 2011 Jun 14;11:36. doi: 10.1186/1471-2466-11-36. BMC Pulm Med. 2011. PMID: 21672193 Free PMC article.
-
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2. Cochrane Database Syst Rev. 2022. PMID: 36373977 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2017 Mar 21;3(3):CD010673. doi: 10.1002/14651858.CD010673.pub2. Cochrane Database Syst Rev. 2017. PMID: 28322440 Free PMC article.
-
Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2017 Jun 19;6(6):CD010010. doi: 10.1002/14651858.CD010010.pub3. Cochrane Database Syst Rev. 2017. PMID: 28626902 Free PMC article.
Cited by
-
Chronic obstructive pulmonary disease.Indian J Med Res. 2013 Feb;137(2):251-69. Indian J Med Res. 2013. PMID: 23563369 Free PMC article. Review.
-
Multistage analysis of variants in the inflammation pathway and lung cancer risk in smokers.Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1213-21. doi: 10.1158/1055-9965.EPI-12-0352-T. Epub 2012 May 9. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22573796 Free PMC article.
-
The coexistence of ROS1-rearranged lung adenocarcinoma and pulmonary tuberculosis in a critical ill young patient.J Int Med Res. 2020 Mar;48(3):300060519883752. doi: 10.1177/0300060519883752. Epub 2019 Nov 29. J Int Med Res. 2020. PMID: 31779512 Free PMC article.
-
Navigating patient journey in early diagnosis of lung cancer in India.Lung India. 2023 Jan-Feb;40(1):48-58. doi: 10.4103/lungindia.lungindia_144_22. Lung India. 2023. PMID: 36695259 Free PMC article. Review.
-
Investigating efficacy of "microbiota modulation of the gut-lung Axis" combined with chemotherapy in patients with advanced NSCLC: study protocol for a multicenter, prospective, double blind, placebo controlled, randomized trial.BMC Cancer. 2021 Jun 22;21(1):721. doi: 10.1186/s12885-021-08448-6. BMC Cancer. 2021. PMID: 34157996 Free PMC article. Clinical Trial.
References
-
- Stewart BW, Kleihues P, editors. Lyons, France: IARC Press; 2003. World Cancer Report.342
-
- Peek RM, Jr, Mohla S, DuBois RN. Inflammation in the genesis and perpetuation of cancer: summary and recommendations from a national cancer institute-sponsored meeting. Cancer Res. 2005;65:8583–8586. - PubMed
-
- Ballaz S, Mulshine JL. The potential contributions of chronic inflammation to lung carcinogenesis. Clin Lung Cancer. 2003;5:46–62. - PubMed
-
- Rakoff-Nahoum S, Medzhitov R. Toll-like receptors and cancer. Nat Rev Cancer. 2009;9:57–63. - PubMed
-
- Weitzman SA, Gordon LI. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood. 1990;76:655–663. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical